-
公开(公告)号:US11383059B2
公开(公告)日:2022-07-12
申请号:US17459058
申请日:2021-08-27
Applicant: VERO Biotech Inc.
Inventor: David P. Rounbehler , David H. Fine
Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.